This site is intended for health professionals only

Sanofi pulls US rimonabant application

teaser

It comes as no surprise but Sanofi-Aventis has withdrawn its marketing application to gain approval in the USA for its obesity drug Acomplia






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x